[Modifiable cardiovascular risk factors: which ones are we really modifying?].
While efforts to identify the underlying mechanisms that lead to endovascular atherogenesis continue, the clinical management of the modifiable cardiovascular risk factors should depend on the most advantageous risk-benefit and cost-effective therapies. However these efforts probably will not have a significant impact in the population at risk unless an improvement in the socioeconomic factors of cardiovascular risk occurs. The ongoing global obesity epidemic reinforces the need for these changes. Public and privately sponsored programs and policies to improve education and access to health resources are important components of this process .